Chlamydia | Top 6 novel treatment findings

Implementation of rapid testing for gonorrhoea and chlamydia reduces care costs for patients with STIs.

Significant decrease in time-to-notification for test results and a 7.5% reduction in mean cost per episode of care, while maintaining staff capacity and service activity levels.

Study published: 2022-05-10

Doxycycline reduces STIs in women

The trial indicated a high prevalence of STIs among participants, suggesting that doxycycline PEP could be an effective intervention for STI prevention in this population.

Study published: 2022-04-01

Emergency departments support expedited partner therapy

The study found that 79% of medical directors supported EPT, with increased awareness linked to higher support levels. EPT is associated with preventing sequelae of untreated STIs, which was rated as extremely important by 44% of respondents.

Study published: 2023-04-03

Accelerated partner therapy reduces chlamydia reinfection

The study found that APT likely caused a small reduction in repeat chlamydia infections and increased the proportion of sexual partners treated compared to usual care alone.

Study published: 2021-08-05

HIV pre-exposure prophylaxis reduces sexually transmitted infections in U.S. military service members.

The study found that entry into PrEP care reduced the overall risk of STIs among military service members, likely due to increased STI prevention counseling and awareness.

Study published: 2022-08-10

The SAFE strategy reduces active trachoma in children.

The study found a significant association between various environmental and hygiene factors and the prevalence of active trachoma, indicating that improved sanitation and hygiene practices could reduce the incidence of the disease.

Study published: 2022-02-07